Ashwin Telang
Ashwin is a content writer at Emerj and a student at Northwestern University studying Journalism and Economics. He has prior experience publishing with several news outlets and research journals.
Articles by Ashwin
4 articles
Cencora, formerly known as AmerisourceBergen, is a leading global pharmaceutical solutions provider focused on delivering healthcare products and optimizing the patient journey. The company collaborates with pharmaceutical manufacturers, healthcare providers, and pharmacies to ensure that patients can access necessary therapies effectively.
Faced with challenges surrounding growing geopolitical tensions, the global shipping and procurement industry is grappling with unprecedented challenges that are reshaping traditional logistics frameworks.
Drug development carries one of the greatest financial risk profiles in the life-science industry. Approximately 90% of drug candidates fail, according to The American Society for Biochemistry and Molecular Biology — a significant share stemming from regulatory hurdles and a resulting lack of clinical efficacy.
In 2020, we wrote about the early but fertile stage of AI development at Johnson and Johnson. Since then, the COVID-19 pandemic and improvements to machine learning have forced important changes in how J&J is using artificial intelligence.